Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.62 |
| ▸ | IDO1 | P14902 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6645015 | 0.93 | RAB9A (0.61) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL4725847 | 0.93 | HTR2A (0.59) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL1029307 | 0.93 | HTR2A (0.59) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL6141153 | 0.92 | HTR2A (0.59) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL9208980 | 0.92 | HTR2A (0.56) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL10949489 | 0.92 | HTR2A (0.56) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL10639376 | 0.90 | HTR2A (0.54) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL6778096 | 0.90 | HTR2A (0.54) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL7289565 | 0.90 | IDO1 (0.64) | HTR2AIDO1RAB9AAKR1C3HTT | |
| SCHEMBL9676749 | 0.90 | HTR2A (0.57) | HTR2AIDO1RAB9AAKR1C3HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2233 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035402-A1 | C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF | ZIKANI THERAPEUTICS INC (US) | 2026-02-05 | — | — | US | claimed |
| CN-119350283-A | Prazomycin impurity H and preparation method thereof | 上海上药新亚药业有限公司 | 2025-01-24 | — | — | CN | claimed |
| US-12060334-B2 | 3-substituted phenazine derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-08-13 | — | — | US | claimed |
| US-11634449-B2 | Macrolides and methods of their preparation and use | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-04-25 | — | — | US | claimed |
| CN-115611933-A | Process for preparing arginase inhibitors and synthetic intermediates thereof | 因赛特公司 | 2023-01-17 | — | — | CN | claimed |
| EP-3649135-B1 | SYNTHESIS OF HALICHONDRINS | HARVARD COLLEGE (US) | 2022-12-28 | — | — | EP | claimed |
| US-20220332747-A1 | MACROLIDES AND METHODS OF THEIR PREPARATION AND USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-10-20 | — | — | US | claimed |
| EP-3291676-B1 | MITRAGYNINE ANALOGS AND USES THEREOF | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-08-17 | — | — | EP | claimed |
| US-11241435-B2 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | THE GENERAL HOSPITAL CORPORATION (US) | 2022-02-08 | — | — | US | claimed |
| WO-2022016195-A1 | PROCESSES FOR THE PREPARATION OF ARGINASE INHIBITORS AND THEIR SYNTHETIC INTERMEDIATES | INCYTE CORPORATION (US) | 2022-01-20 | — | — | WO | claimed |
| WO-2005058246-A2 | METHOD FOR PREPARING RADIOLABELED THYMIDINE | MOLECULAR TECHNOLOGIES, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| US-20050131224-A1 | Method for preparing radiolabeled thymidine | CTI PET SYSTEMS, INC. | 2005-06-16 | — | — | US | claimed |
| EP-0889901-B1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF LHRH ANTAGONISTS | ABBOTT LAB (US) | 2001-09-19 | — | — | EP | claimed |
| EP-0914334-B1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF LHRH ANTAGONISTS | ABBOTT LAB (US) | 2001-05-30 | — | — | EP | claimed |
| EP-0914334-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF LHRH ANTAGONISTS | Abbott Laboratories (US) | 1999-05-12 | — | — | EP | claimed |
| EP-0889901-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF LHRH ANTAGONISTS | Abbott Laboratories (US) | 1999-01-13 | — | — | EP | claimed |
| US-5710247-A | DEPROTECTING OLIGOPEPTIDE; COUPLING | ABBOTT LABORATORIES (US) | 1998-01-20 | — | — | US | claimed |
| US-5710246-A | COUPLING OLIGOPEPTIDES; DEPROTECTING | ABBOTT LABORATORIES (US) | 1998-01-20 | — | — | US | claimed |
| WO-1997034924-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF LHRH ANTAGONISTS | ABBOTT LABORATORIES (US) | 1997-09-25 | — | — | WO | claimed |
| WO-1997034923-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF LHRH ANTAGONISTS | ABBOTT LABORATORIES (US) | 1997-09-25 | — | — | WO | claimed |